Designer DNA Vaccine for Cancer Immunotherapy

Researchers at The Wistar Institute report that they have used a new structurally designed synthetic DNA vaccine to simultaneously target multiple members of a family of proteins that are specifically overexpressed in several types of cancer. They say their approach addressed a difficult issue in cancer immunotherapy, specifically how to simultaneously drive antitumor immune responses against multiple tumor antigens in a single, easily delivered formulation and could simplify immunotherapy treat